NYSE
19.24USD
-0.07 (-0.36%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
36.9B
P/E
—
EPS
—
Beta
0.44
52W range
14.02-22.285
Day range
18.95–19.34
Open
19.19
Prev close
19.31
Volume
15.3M
Avg volume
20.6M
Dividend
0.83
IPO
2023-05-04
https://www.zacks.com/stock/news/2963527/kenvue-benefits-from-consumer-health-trends-and-margin-expansion?cid=CS-STOCKNEWSAPI-FT-analyst_blog_plus|zer_report_insights-2963527 · 7/29/2026+0.20
https://www.zacks.com/stock/news/2963529/kenvue-s-brand-strength-and-growth-drivers-shape-its-future-outlook?cid=CS-STOCKNEWSAPI-FT-analyst_blog_plus|zer_report_insights-2963529 · 7/29/2026+0.40
https://www.businesswire.com/news/home/20260723599147/en/Kenvue-to-Announce-Second-Quarter-2026-Results-on-August-6-2026/ · 7/23/2026+0.00
https://www.fool.com/investing/2026/07/19/is-it-too-late-to-buy-johnson-johnson-after-its-bl/ · 7/19/2026+0.10
https://www.cnbc.com/2026/07/06/jim-cramer-stocks-buy-during-market-rotation.html · 7/6/2026+0.00
https://www.fool.com/investing/2026/06/25/spacex-stock-down-23-ipo-this-happen-next-big-move/ · 6/25/2026+0.00
https://www.globenewswire.com/news-release/2026/06/15/3312168/35903/en/mondel%c4%93z-international-names-amit-banati-executive-vice-president-and-chief-financial-officer.html · 6/15/2026+0.00
https://www.zacks.com/commentary/2932759/best-consumer-dividend-stocks-to-buy-now-has-kvue-mov?cid=CS-STOCKNEWSAPI-FT-investment_ideas-2932759 · 6/5/2026+1.00
https://seekingalpha.com/article/4908844-kimberly-clark-buy-this-dividend-aristocrat-poised-to-rebound · 5/26/2026+0.40
https://www.zacks.com/commentary/2918560/best-income-stocks-to-buy-for-may-11th?cid=CS-STOCKNEWSAPI-FT-zacks_1_rank_additions|income_additions-2918560 · 5/11/2026+1.00
https://seekingalpha.com/article/4901100-diamond-hill-capital-management-mid-cap-strategy-q1-2026-drivers-and-decisions · 5/8/2026+0.50
https://www.zacks.com/stock/news/2916717/kenvue-kvue-q1-earnings-and-revenues-beat-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2916717 · 5/7/2026+0.60
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
